FDA Import Refusal AEK-0228257-1/50002/1 — DOUGLAS PHARMACEUTICALS LTD
The FDA refused shipment AEK-0228257-1/50002/1 from DOUGLAS PHARMACEUTICALS LTD (New Zealand) on Apr 3, 2026. The refused product falls under Drugs and Biologics — SERTRALINE HYDROCHLORIDE (ANTI-DEPRESSANT). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Apr 3, 2026
- Country
- New Zealand
- Product Category
- Drugs and Biologics
- Product Code
- 61NDB78 SERTRALINE HYDROCHLORIDE (ANTI-DEPRESSANT)
- Charges
- 75